Search Results 7451-7460 of 34194 for oral

  1. SYMPHONY: A Study of Macitentan in Pulmonary Arterial Hypertension to Validate the PAH-SYMPACT - Mayo Clinic

    For patients on oral diuretics, stable doses for at least 4 weeks prior to Visit 2; Men or women aged 18 or older. A woman is considered to be of childbearing ...

  2. Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea - Mayo Clinic

    Participants with a history of using devices for OSA treatment, including CPAP, oral or nasal devices, or positional devices, may enroll as long as the ...

  3. Histology of Care Delivery in the ICU - Clinical Trials

    Oral consent will be requested for patients with no barriers to consent (e.g., cognitive impairment). In the case where this cannot occur, the patient's ...

  4. Head and neck cancers - Doctors and departments - Mayo Clinic

    ... Oral and throat cancer, Salivary gland cancer, Thyroid cancer, Head and neck cancer, Skin cancer, Thyroid nodule, Salivary gland tumor, Laryngeal cancer ...

  5. Head and neck cancers - Doctors and departments - Mayo Clinic

    r, Oral and throat cancer, Mouth cancer, Thyroid cancer, Head and neck cancer, Salivary gland tumor, Soft palate cancer, Nasal and paranasal tumors ...

  6. Head and neck cancers - Doctors and departments - Mayo Clinic

    Oral and Maxillofacial Surgery · Otolaryngology (ENT)/Head and Neck Surgery · Pediatric Hematology/Oncology · Pediatric Otolaryngology · Pediatrics · Physical ...

  7. A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamics Of Satralizumab In Patients With Anti-N-Methyl-D-Aspartic Acid Receptor (NMDAR) Or Anti-Leucine-Rich Glioma-Inactivated 1 (LGI1) Encephalitis (Cielo) - Mayo Clinic

    * Treatment with oral cyclophosphamide within 1 year prior to baseline Treatment with any investigational drug (including bortezomib) within 24 weeks prior ...

  8. CNS Tumors With Latent Residual Disease To Guide Individualized Therapies - Mayo Clinic

    ... oral medication NOTE: This includes but not limited to, refractory vomiting, gastric resection/bypass, or duodenal/jejunal resection. Patients with known ...

  9. Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma - Mayo Clinic

    ... oral cavity, or nasal mucosa. Note: Other protocol defined Inclusion/Exclusion Criteria may apply. Eligibility last updated 11/20/2024. Questions regarding ...

  10. Clinical Trials - Tesevatinib in Subjects With ADPKD

    Participation eligibility · intrauterine device plus 1 barrier method; · on stable doses of hormonal contraception for at least 3 months (eg, oral, injectable, ...